Solon, OH, United States of America

Ping Ma

This inventor holds 1 USPTO granted patent. Top assignee: Hikma Pharmaceuticals USA Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ping Ma. Retrieved from https://idiyas.com/inventor/ping-ma-n937ornh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Ping Ma in Pharmaceutical Formulations

Introduction

Ping Ma is an accomplished inventor based in Solon, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid formulations for intravenous administration.

Latest Patents

One of his notable patents is for vasopressin liquid formulations. This patent describes a liquid pharmaceutical composition that includes vasopressin or a pharmaceutically acceptable salt thereof. The formulation is designed to include a lactate buffer or lactic acid, optionally combined with a pH adjuster. The pharmaceutical composition can maintain a pH ranging from about 3.0 to about 4.1, demonstrating improved stability for long-term storage, especially at room temperature. Ping Ma holds 1 patent in this area.

Career Highlights

Ping Ma is currently associated with Hikma Pharmaceuticals USA Inc., where he continues to innovate in pharmaceutical formulations. His work focuses on enhancing the stability and efficacy of liquid medications, which is crucial for patient care.

Collaborations

He collaborates with various professionals in the field, including Gyongyi Szakalas-Gratzl, to further advance his research and development efforts.

Conclusion

Ping Ma's contributions to pharmaceutical innovations, particularly in vasopressin formulations, highlight his commitment to improving medical treatments. His work exemplifies the importance of research and development in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…